Hip circumference, height and risk of type 2 diabetes: Systematic review and meta-analysis

Obesity Reviews

Volumn 13, Issue 12, 2012, Pages 1172-1181

  Janghorbani, M ^a   Momeni, F ^a   Dehghani, M ^a  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Diabetes mellitus; Height; Hip circumference; Meta analysis

Indexed keywords

BODY HEIGHT; GENETIC HETEROGENEITY; GEOGRAPHIC DISTRIBUTION; HIP; HUMAN; NON INSULIN DEPENDENT DIABETES MELLITUS; REVIEW; RISK FACTOR; SEX DIFFERENCE; SYSTEMATIC REVIEW;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BODY HEIGHT; COMORBIDITY; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE; MIDDLE AGED; OBESITY; ODDS RATIO; SEX FACTORS; WAIST CIRCUMFERENCE; WAIST-HIP RATIO; YOUNG ADULT;

EID: 84868536109     PISSN: 14677881     EISSN: 1467789X     Source Type: Journal    
DOI: 10.1111/j.1467-789X.2012.01030.x     Document Type: Review

References (47)

1. Vazquez G, Duval S, Jacobs DR Jr, Silventoinen K. Comparison of body mass index, waist circumference, and waist/hip ratio in predicting incident diabetes: a meta-analysis. Epidemiol Rev 2007; 29: 115-128.
2. Janghorbani M, Amini M. Comparison of body mass index with abdominal obesity indicators and waist-to-stature ratio for prediction of type 2 diabetes: the Isfahan diabetes prevention study. Obes Res Clin Pract 2010; 4: e25-e32.
3. Snijder MB, Dekker JM, Visser M etal. Associations of hip and thigh circumferences independent of waist circumference with the incidence of type 2 diabetes: the Hoorn study. Am J Clin Nutr 2003; 77: 1192-1197.
4. Parker ED, Pereira MA, Stevens J, Folsom AR. Association of hip circumference with incident diabetes and coronary heart disease: the atherosclerosis risk in communities study. Am J Epidemiol 2009; 169: 837-847.
5. Bozorgmanesh M, Hadaegh F, Zabetian A, Azizi F. Impact of hip circumference and height on incident diabetes: results from 6-year follow-up in the Tehran lipid and glucose study. Diabet Med 2011; 28: 1330-1336.
6. Snijder MB, Zimmet PZ, Visser M etal. Independent and opposite associations of waist and hip circumferences with diabetes, hypertension and dyslipidemia: the AusDiab study. Int J Obes Relat Metab Disord 2004; 28: 402-409.
7. Esmaillzadeh A, Mirmiran P, Azadbakht L etal. Independent and inverse association of hip circumference with metabolic risk factors in Tehranian adult men. Prev Med 2006; 42: 354-357.
8. Seidell JC, Han TS, Feskens EJ, Lean ME. Narrow hips and broad waist circumferences independently contribute to increased risk of non-insulin-dependent diabetes mellitus. J Intern Med 1997; 242: 401-406.
9. Hartz AJ, Rupley DC, Rimm AA. The association of girth measurements with disease in 32, 856 women. Am J Epidemiol 1984; 119: 71-80.
10. Lissner L, Björkelund C, Heitmann BL etal. Larger hip circumference independently predicts health and longevity in a Swedish female cohort. Obes Res 2001; 9: 644-646.
11. Wang S, Pan W, Hwu C etal. Incidence of NIDDM and the effects of gender, obesity, and hyperinsulinaemia in Taiwan. Diabetologia 1997; 40: 1431-1438.
12. Njølstad I, Amesen E, Lund-Larsen PG. Sex differences in risk factors for clinical diabetes mellitus in a general population: a 12-year follow-up of the Finnmark Study. Am J Epidemiol 1998; 147: 49-58.
13. Lorenzo C, Williams K, Stern MP, Haffner SM. Height, ethnicity and the incidence of diabetes: the San Antonio Heart Study. Metabolism 2009; 58: 1530-1535.
14. Janghorbani M, Amini M. Associations of hip circumference and height with incidence of type 2 diabetes: the Isfahan Diabetes Prevention Study. Acta Diabetol 2011. doi: 10.1007/s00592-011-0351-4 (in press).
15. Schulze MB, Heidemann C, Schienkiewitz A etal. Comparison of anthropometric characteristics in predicting the incidence of type 2 diabetes in the EPIC-Potsdam Study. Diabetes Care 2006; 29: 1921-1923.
16. Esmaillzadeh A, Mirmiran P, Habibi Moeini S, Azizi F. Larger hip circumference independently contributed to reduced metabolic risks in Tehranian adult women. Int J Cardiol 2006; 108: 338-345.
17. Conway B, Xiang YB, Villegas R etal. Hip circumference and the risk of type 2 diabetes in middle-aged and elderly men and women: the Shanghai women and Shanghai men's health studies. Ann Epidemiol 2011; 21: 358-366.
18. Kaur P, Radhakrishnan E, Sankarasubbaiyan S etal. A comparison of anthropometric indices for predicting hypertension and type 2 diabetes in a male industrial population of Chennai, South India. Ethn Dis 2008; 18: 31-36.
19. Stroup DF, Berlin JA, Morton SC etal. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000; 283: 2008-2012.
20. Lawlor DA, Ebrahim S, Davey Smith G. The association between components of adult height and type II diabetes and insulin resistance: British Women's Heart and Health Study. Diabetologia 2002; 45: 1097-1106.
21. Liu J, Tan H, Jeynes B. Is femur length the key height component in risk prediction of type 2 diabetes among adults? Diabetes Care 2009; 32: 739-740.
22. Janghorbani M, Amini M. Effects of gender and height on the oral glucose tolerance test: the Isfahan Diabetes Prevention Study. Rev Diabet Stud 2008; 5: 163-170.
23. Han TS, Feskens EJM, Lean MEJ, Seidell JC. Associations of body composition with type 2 diabetes mellitus. Diabet Med 1998; 15: 129-135.
24. Olatunbosun ST, Bella AF. Relationship between height glucose tolerance, and hypertension in an urban African black adult population: a case for the 'thrifty phenotype' hypothesis. J Natl Med Assoc 2000; 92: 265-268.
25. Asao K, Kao WHL, Baptiste-Roberts K etal. Short stature and the risk of adiposity, insulin resistance, and type 2 diabetes in middle age. Diabetes Care 2006; 29: 1632-1637.
26. Wang Z, Hoy WE. Body size measurements as predictors of type 2 diabetes in Aboriginal people. Int J Obes 2004; 28: 1580-1584.
27. Wang Z, Rowley K, Wang Z etal. Anthropometric indices and their relationship with diabetes, hypertension and dyslipidemia in Australian Aboriginal people and Torres Strait Islanders. Eur J Cardiovasc Prev Rehabil 2007; 14: 172-178.
28. Greenland S. Quantitative methods in the review of epidemiologic literature. Epidemiol Rev 1987; 9: 1-30.
29. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-188.
30. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21: 1539-1558.
31. Higgins JP, Green S (eds). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0. The Cochrane Collaboration, 2011. [WWW document]. URL http://www.cochrane-handbook.org (accessed August 2012).
32. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. Br Med J 1997; 315: 629-634.
33. Egger M, Smith GD, Altman DG. Systematic Reviews in Health Care: Meta-Analysis in Context. BMJ Publishing Group: London, UK, 2001.
34. Sutton AJ, Duval SJ, Tweedie RL etal. Empirical assessment of effect of publication bias on meta-analyses. BMJ 2000; 320: 1574-1577.
35. Manolopous K, Karpe F, Frayn K. Gluteofemoral body fat as a determinant of metabolic health. Int J Obes 2010; 34: 949-959.
36. Snijder MB, Dekker JM, Visser M etal. Trunk fat and leg fat have independent and opposite associations with fasting and postload glucose levels: the Hoorn Study. Diabetes Care 2004; 27: 372-377.
37. Ferreira I, Snijder MB, Twisk JW etal. Central fat mass versus peripheral fat and lean mass: opposite (adverse versus favorable) associations with arterial stiffness? The Amsterdam Growth and Health Longitudinal Study. J Clin Endocrinol Metab 2004; 89: 2632-2639.
38. Tankó LB, Bagger YZ, Alexandersen P, Larsen PJ, Christiansen C. Peripheral adiposity exhibits an independent dominant antiatherogenic effect in elderly women. Circulation 2003; 107: 1626-1631.
39. Van Pelt RE, Evans EM, Schechtman KB etal. Contributions of total and regional fat mass to risk for cardiovascular disease in older women. Am J Physiol Endocrinol Metab 2002; 282: E1023-E1028.
40. Williams MJ, Hunter GR, Kekes-Szabo T etal. Regional fat distribution in women and risk of cardiovascular disease. Am J Clin Nutr 1997; 65: 855-860.
41. Björntorp P. 'Portal' adipose tissue as a generator of risk factors for cardiovascular disease and diabetes. Arteriosclerosis 1990; 10: 493-496.
42. Hirschhorn JN, Lindgren CM, Daly MJ etal. Genomewide linkage analysis of stature in multiple populations reveals several regions with evidence of linkage to adult height. Am J Hum Genet 2001; 69: 106-116.
43. Park HS, Yim KS, Cho SI. Gender differences in familial aggregation of obesity-related phenotypes and dietary intake pattern in Korean families. Ann Epidemiol 2004; 14: 486-491.
44. Li JK, Ng MC, So WY etal. Phenotypic and genetic clustering of diabetes and metabolic syndrome in Chinese families with type 2 diabetes mellitus. Diabetes Metab Res Rev 2006; 22: 46-526.
45. Ramachandran A, Snehalatha C, Satyavani K etal. Cosegregation of obesity with familial aggregation of type 2 diabetes mellitus. Diabetes Obes Metab 2000; 2: 149-154.
46. Sandhu MS, Heald AH, Gibson JM etal. Circulating concentrations of insulin-like growth factor-I and development of glucose intolerance: a prospective observational study. Lancet 2002; 359: 1740-1745.
47. Mattila C, Knekt P, Mannisto S etal. Serum 25-hydroxyvitamin D concentration and subsequent risk of type 2 diabetes. Diabetes Care 2007; 30: 2569-2570.